Exploring the biosynthetic potential of Nostoc : chemical diversity and genomics-driven discovery of novel natural products
Аннотация
This review summarizes the chemical diversity, biological activities, biosynthetic pathways, and experimental evidence of natural products reported from Nostoc . Among the 75 metabolites compiled, peptides and peptide-derived metabolites, including NRPS products, PKS–NRPS hybrids, and RiPPs, represented the largest group (45.3%), followed by polyketides, PKS-associated metabolites, and glycolipids (22.7%). Several compounds, including varlaxins, suomilide F, menominins, aulosirazole, cyanopeptolins, and nostocyclopeptides, have strong experimental evidence for their biological activities, whereas many other metabolites remain biologically untested or are mainly associated with predicted or inferred functions. Overall, structural characterization has progressed faster than biological validation for several metabolite groups. Genome mining has revealed a large diversity of BGCs in Nostoc , but predicted BGCs should be distinguished from BGC – metabolite associations and experimentally validated pathways. Integration of genomics with metabolomics, stable-isotope labeling, transcriptomics, genetic manipulation, heterologous expression, and biochemical characterization provides different levels of evidence for pathway function. BGC expression and metabolite production can be influenced by environmental conditions, biological interactions, and pathway-specific regulation. Structural diversity can also result from changes in BGC architecture, including recombination and module loss. Potential applications of Nostoc and its metabolites extend to pharmaceutical, agricultural, nutraceutical, and environmental biotechnology. Their further development, however, is still limited by biosafety, low metabolite yields, multistep purification, production reproducibility, stability, scale-up, and heterologous expression. Future studies should prioritize predicted BGCs using integrated omics, directly validate BGC – metabolite relationships, examine the regulation of poorly expressed pathways, and improve production reproducibility while also considering biological activity, safety, stability, and scalability.